Point72 Asset Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.48M Buy
+167,896
New +$2.48M ﹤0.01% 809
2024
Q3
Sell
-320,580
Closed -$2.64M 1704
2024
Q2
$2.64M Sell
320,580
-551,520
-63% -$4.53M 0.01% 718
2024
Q1
$6.72M Buy
+872,100
New +$6.72M 0.02% 685
2023
Q4
Sell
-13,572
Closed -$121K 2093
2023
Q3
$121K Sell
13,572
-1,772,407
-99% -$15.8M ﹤0.01% 1250
2023
Q2
$27.4M Buy
+1,785,979
New +$27.4M 0.08% 281
2022
Q4
Sell
-327,706
Closed -$8.08M 1411
2022
Q3
$8.08M Buy
+327,706
New +$8.08M 0.03% 527
2022
Q2
Sell
-33,300
Closed -$858K 1343
2022
Q1
$858K Buy
+33,300
New +$858K ﹤0.01% 894
2021
Q2
Sell
-1,608,126
Closed -$40.2M 1111
2021
Q1
$40.2M Buy
1,608,126
+987,126
+159% +$24.6M 0.19% 137
2020
Q4
$16.9M Sell
621,000
-420,405
-40% -$11.5M 0.08% 298
2020
Q3
$19.2M Buy
1,041,405
+655,279
+170% +$12.1M 0.1% 268
2020
Q2
$7.88M Buy
386,126
+82,746
+27% +$1.69M 0.05% 371
2020
Q1
$4.43M Buy
+303,380
New +$4.43M 0.04% 379
2019
Q3
Sell
-238,900
Closed -$4.8M 1385
2019
Q2
$4.8M Sell
238,900
-27,200
-10% -$547K 0.03% 457
2019
Q1
$6.02M Sell
266,100
-433,900
-62% -$9.82M 0.03% 451
2018
Q4
$15.8M Buy
700,000
+51,400
+8% +$1.16M 0.08% 268
2018
Q3
$18.6M Buy
648,600
+223,500
+53% +$6.42M 0.08% 238
2018
Q2
$11.6M Sell
425,100
-502,300
-54% -$13.7M 0.05% 326
2018
Q1
$20.7M Buy
927,400
+59,600
+7% +$1.33M 0.09% 236
2017
Q4
$18.3M Buy
867,800
+392,229
+82% +$8.26M 0.08% 263
2017
Q3
$11.8M Sell
475,571
-497,929
-51% -$12.4M 0.05% 294
2017
Q2
$18.9M Buy
973,500
+8,700
+0.9% +$169K 0.11% 221
2017
Q1
$17.8M Buy
964,800
+552,065
+134% +$10.2M 0.1% 247
2016
Q4
$7.81M Buy
412,735
+261,935
+174% +$4.96M 0.05% 342
2016
Q3
$3.38M Sell
150,800
-24,000
-14% -$537K 0.02% 454
2016
Q2
$3.11M Buy
+174,800
New +$3.11M 0.02% 456
2015
Q4
Sell
-194,000
Closed -$3.93M 787
2015
Q3
$3.93M Sell
194,000
-49,300
-20% -$999K 0.03% 421
2015
Q2
$8.07M Buy
+243,300
New +$8.07M 0.06% 338